IMB’s Mathilde Desselle has won the Queensland Women in Technology (WiT) InfoTech Professional Award for her leadership of biomedical research programs and facilities in the fields of genomics, bioinformatics and drug discovery.

IMB research could lead to a new treatment for Parkinson’s disease, with future potential applications to nearly 50 other disorders.

Researchers from IMB and Imperial College London have developed a method to distinguish viral and bacterial infections in children, which will save lives and reduce antibiotic use.

IMB researcher Professor Kirill Alexandrov has received funding from the Bill & Melinda Gates Foundation to develop a cheap, portable biosensor to detect a range of infectious diseases, including Dengue fever and Zika virus.

IMB spin-out biotech company Protagonist Therapeutics Inc is a step closer to developing a new drug that would benefit millions of people worldwide.

The National Health and Medical Research Council has named two UQ projects among its 10 of the Best Research Projects 2015, including IMB Group Leader Professor David Craik's project named “The scorpion king: lighting the way to defeating brain cancer”. These projects have led to ground-breaking medical discoveries and important changes to healthcare.

Applications are now open for the IMB Research Advancement Award, offering brilliant prospective PhD students the opportunity to secure a $30,000 top-up scholarship to support their studies at IMB.

IMB has welcomed three new research groups to bolster its investigations into neurological and psychiatric disorders, including motor neuron disease, Parkinson’s disease, dementia, autism and schizophrenia.

It is possible to combine family and a love of science. PhD graduate Rubbiya Ali looks back on everything she’s achieved at UQ, including mapping microalgae to help produce more efficient biofuels and having a son.